
5 years on, Sassoon hospital awaits approval for additional beds at 11-storey building
The building houses the paediatric, pulmonary, orthopaedic and radiology departments.
It has affected recruitment of staff to handle these additional patients and funds needed to buy medicines and consumables, officials at the BJMC & SGH said. They added that once the file is approved by MEDD, it will be sent to the state finance department for final approval.
The building was planned in 2009 after the swine flu epidemic but took 11 years to construct.
When the Covid-19 pandemic struck, the building was thrown open on an urgent basis to admit serious patients.
Dr Eknath Pawar, dean at BJMC & SGH, said, "As of now we are working at 66% of staff strength at the hospital and medical college. For the hospital's old buildings, we have an approval for 1,296 beds and for that we have an approved staff strength of 3,091."
As per the information obtained from the hospital, of the 2,359 approved posts for class 1-4 employees at the old buildings, only 1,565 are filled and 794 are vacant.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Thị trường có dấu hiệu suy thoái không?
IC Markets
Đăng ký
Undo
Of the 732 approved posts for BJ Medical College, 424 are filled and 308 are vacant.
Dr Pawar said, "We had in 2022 sent a proposal seeking approval for 504 beds at the 11-storey building and also the staff required for those beds. We are yet to get a response on it. About the vacancies in the approved posts, we have already issued a tender to fill in the class four posts and in the next two months, 350 workers will be recruited.
For class 1 and 2 posts, recruitment process is under way via the Maharashtra Public Service Commission.
"
The acute shortage of staff gravely affects patient services. Maya Jagtap, who has her relative admitted at the 11-storey building's orthopedic department ward, said, "Often there are no nurses or class 4 workers available to take the patient from the ward to the radiology department for scans. We have to be near the building all the time so that we can help our kin."
Hasan Mushrif, minister of medical education, said, "I will look into it and if the approval is pending at our level, I will get it done in one week. I will immediately follow up on the proposal with the secretary of MEDD."
Dheeraj Kumar, secretary, MEDD, could not be contacted for his comment despite several attempts. Rajiv Nivatkar, commissioner, MEDD, said, "I am out of town now; I will get back when I have information."
City-based health activist and an alumnus of BJ Medical College, Dr Sanjay Dabhade, said that first it took 11 years for the 11-storey building to be constructed and then it was opened only when the Covid-19 pandemic broke out and now govt is delaying approving the beds.
"The hospital is always struggling to manage the existing patient load but with additional patients coming in, it will soon reach a breaking point. Why should it take five years to approve the beds which are already in use? This hospital is not only the hope for serious patients who come from different districts of Maharashtra but also for many homeless and poor people. Without enough staff, patient services are hampered gravely and there would be constant conflict between patients and healthcare workers.
State govt must immediately approve these beds and the staff required," he said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Indian Express
31 minutes ago
- New Indian Express
Karnataka CM Siddaramiah's claims on Covid vaccine factually wrong, says Biocon founder
BENGALURU: Refuting Chief Minister Siddaramaiah's remark that the Covid-19 vaccine might be a reason for a sudden spike in heart attack-related deaths, Biocon founder Kiran Mazumdar-Shaw on Wednesday said that the vaccines were approved under the 'Emergency Use Authorisation' framework, adding that the CM was factually incorrect, contributing to public misinformation. On July 1, Siddaramaiah had claimed that it cannot be denied that the hasty approval and distribution of the Covid-19 vaccine to the public could also be a reason for heart attack deaths. Immediately, the Union Health Ministry took objection to his statement, and dismissed the Covid vaccine link with heart attack deaths. 'Covid-19 vaccines developed in India were approved under the Emergency Use Authorisation framework, following rigorous protocols aligned with global standards for safety and efficacy,' Kiran said on Wednesday, in her reply to the CM's X post. 'To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation,' the Biocon founder stated. She further went on to say that these vaccines have saved millions of lives and, like all vaccines, may cause side effects in a very small number of individuals. 'It is important to acknowledge the science and data-driven processes behind their development, rather than engage in retrospective blame,' she ended.


Hindustan Times
42 minutes ago
- Hindustan Times
Dengue's most dangerous serotype, DENV-2, circulating in Pune: Study
A major study being conducted in the city has revealed the presence of dengue virus serotype 2 (DENV-2), the variant that is most commonly linked with severe cases and hospitalisation. This serotype has been found in 65-70% of the samples tested in the city, with most of them belonging to Genotype II - Lineage F11. The finding has raised serious public health concerns, especially since the monsoon season is known to cause an upsurge in mosquito-borne illnesses. The dengue genome sequencing is part of this vertical programme with the Genomics Laboratory at BJMC leading the sequencing work. (REPRESENTATIVE PHOTO) Titled, 'Prospective Observational Study to Map the Dengue Incidence in the Pune Municipal Region', the initiative started on March 24, 2023, through a collaboration between B.J. Medical College (BJMC), Pune, and Pune Knowledge Cluster Foundation. The ongoing study started taking serum samples from April 2023 and has tested around 5,000 samples so far for dengue, using ELISA and rapid diagnostic methods. The data confirmed a sharp seasonal rise in cases during August to October in both 2023 and 2024, consistent with monsoon-related mosquito activity. 'Whole genome sequencing of dengue-positive samples was done to provide data that will help develop vaccines and low-cost molecular diagnostic assays for testing the disease,' BJMC officials said. Dr Rajesh Karyakarte, Professor and Head, Microbiology, BJMC, said, 'We believe this study will contribute valuable data that can be useful in the development of vaccines and affordable molecular diagnostic tests.' The Pune Knowledge Cluster (PKC) is using vector dynamics and viral epidemics to understand the prevalence of infectious diseases. The dengue genome sequencing is part of this vertical programme with the Genomics Laboratory at BJMC leading the sequencing work. Dr Rashmita Das, assistant professor, Microbiology, BJMC, said, 'Preliminary findings reveal that Type 2 was the most frequently identified serotype, detected in approximately 65-70% of the sequenced samples. A small fraction of samples could not be definitively genotyped, indicating the potential presence of novel or divergent strains.' Around 300 samples were tested using PCR to detect the viral genome, and 54 samples underwent whole genome sequencing. Shockingly, DENV-2 was found in 65-70% of the sequenced samples, most of them belonging to Genotype II - Lineage F11, followed by Genotype V. According to experts, DENV-2 is widely known to cause more severe disease, including dengue hemorrhagic fever and dengue shock DENV-3 serotype, like DENV-2, can also lead to severe forms of dengue. However, DENV-3 and DENV-4 were found in less than 5% of the sequences. Dr Eknath Pawar, dean of BJMC and Sassoon General Hospital, said, 'The public health officials should intensify mosquito control measures, particularly in slum areas and construction sites. Citizens should get rid of stagnant water in their houses and surroundings, and use mosquito repellents. They should also avoid self-medication and seek medical attention promptly if symptoms such as high fever, body pain, and rashes appear. Treatment is available free of cost at Sassoon Hospital.' Dengue is a vector-borne viral infection caused by the bite of an infected mosquito. It is caused by four different serotypes of the dengue virus - DENV 1, DENV 2, DENV 3, and DENV 4. Infection can occur due to any one or more than one of the four serotypes. These four serotypes are further subdivided into distinct genotypes.


Indian Express
3 hours ago
- Indian Express
Vaccine manufacturers' body, Serum Institute of India reaffirm COVID-19 vaccine safety
The Indian Vaccine Manufacturers Association (IVMA) has assured that all COVID-19 vaccines in India were approved for emergency use authorisation based on extensive evaluation in preclinical studies and human clinical trials. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' Dr G V J A Harshavardhan, Director General, IVMA, said in a statement released on Thursday. The statement sought to reassure the public on the safety and efficacy of COVID-19 vaccines. 'All COVID-19 vaccines in India were approved for emergency use authorisation [restricted use in emergency situations as per World Health Organization guidelines], he said, adding, 'These approvals were based on extensive evaluation in preclinical studies and human clinical trials, with positive results on safety, efficacy, and immunogenicity of these vaccines.' The IVMA statement comes in the backdrop of the Union health ministry saying on Wednesday that extensive studies by several agencies have 'conclusively established no linkages' between COVID-19 vaccines and sudden deaths. The Serum Institute of India also posted on X that the COVID-19 vaccines were safe and scientifically validated. 'Two large-scale studies by ICMR [Indian Council of Medical Research] and AIIMS [All India Institute of Medical Sciences], as cited by the Ministry of Health have found no link between Covid-19 vaccines and sudden deaths,' SII said. The IVMA statement also noted that prior to their release, all COVID-19 vaccines were tested extensively for safety by the manufacturers and were also provided Batch Release Certification by the Central Drugs Laboratory in Kasauli, Himachal Pradesh, under the Ministry of Health and Family Welfare. 'The strengths of innovation and large-scale, high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem. COVID-19 vaccines manufactured in India were largely responsible for not only controlling the COVID-19 pandemic and restricting its impact on lives, livelihoods, but most importantly, enabling India's economic activity and GDP to rebound and grow to new heights globally,' Dr Harshavardhan said. 'This positive impact of COVID-19 vaccination was not only limited to India, but also to several countries worldwide, under the Government of India's Vaccine Maitri programme…,' he added.